Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication June 20, 2022
- Revision received August 30, 2022
- Published online March 2, 2023.
Article Versions
- previous version (September 2, 2022 - 05:49).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2023 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
- Yizhen Pang*,1,2,
- Liang Zhao*,1,2,
- Tinghua Meng*,1,
- Weizhi Xu1,
- Qin Lin2,
- Hua Wu1,
- Jingjing Zhang3,4,
- Xiaoyuan Chen4,5,6,
- Long Sun1 and
- Haojun Chen1
- 1Department of Nuclear Medicine and Minnan PET Center, First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China;
- 2Department of Radiation Oncology, First Affiliated Hospital of Xiamen University, Xiamen, China;
- 3Department of Diagnostic Radiology, National University of Singapore, Singapore;
- 4Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore;
- 5Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and Faculty of Engineering, National University of Singapore, Singapore; and
- 6Nanomedicine Translational Research Program, NUS Center for Nanomedicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
- For correspondence or reprints, contact Haojun Chen (leochen0821{at}foxmail.com), Long Sun (13178352662{at}163.com), or Xiaoyuan Chen (chen.shawn{at}nus.edu.sg).
↵* Contributed equally to this work.
Statistics from Altmetric.com
Cited By...
Article usage
In this issue
Jump to section
Related Articles
Cited By...
- SNMMI Procedure Standard/EANM Practice Guideline for Fibroblast Activation Protein (FAP) PET
- 68Ga-FAP-2286 PET of Solid Tumors: Biodistribution, Dosimetry, and Comparison with 18F-FDG
- Initial Experience with 68Ga-FAP-2286 PET Imaging in Patients with Urothelial Cancer
- Clinical Evaluation of 68Ga-FAPI-RGD for Imaging of Fibroblast Activation Protein and Integrin {alpha}v{beta}3 in Various Cancer Types
- Clinical Evaluation of 68Ga-FAPI-RGD for Imaging of Fibroblast Activation Protein and Integrin {alpha}v{beta}3 in Various Cancer Types